Small molecule · Antagonist of Muscarinic acetylcholine receptor M3 (CHRM3) · developed by Boehringer Ingelheim
ApprovedFDA, Jan 2004
What is Tiotropium?
Tiotropium is a long-acting antimuscarinic agent that competitively and reversibly antagonizes M3 muscarinic receptors on airway smooth muscle, producing bronchodilation. It is used in maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease and of asthma.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
Spiriva Handihaler, Spiriva Respimat, Spiriva
Drug type
Small molecule
Targets
Muscarinic acetylcholine receptor M3 (CHRM3)
Mechanism
Antagonist of Muscarinic acetylcholine receptor M3 (CHRM3)
From the indications section of the FDA label (version of Aug 17, 2026). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.